Travelers CFO granted 13,026 stock options
The Travelers Companies, Inc. reported an insider equity award for its EVP & Chief Financial Officer, Daniel S. Frey.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Travelers Companies, Inc. reported an insider equity award for its EVP & Chief Financial Officer, Daniel S. Frey. On February 3, 2026, he was granted stock options to buy 13,026 shares of Travelers common stock.
The options have an exercise price of $288.23 per share, become exercisable on February 3, 2029, and expire on February 3, 2036. Following this grant, Frey directly holds 13,026 stock options, with no indirect ownership reported in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 13,026 | $0.00 | $0.00 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TRV executive Daniel S. Frey report on this Form 4?
What are the key terms of Daniel S. Frey’s TRV stock option grant?
How many Travelers stock options does Daniel S. Frey own after this transaction?
Was the Travelers (TRV) Form 4 transaction a purchase, sale, or grant of options?
When can Daniel S. Frey start exercising his TRV stock options and when do they expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.